These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24845788)

  • 21. Bioresorbable Scaffold With Drug-Coated Balloon: A "Biodegradable" Model for Bifurcation Lesions Treatment. The New Intriguing Chapter of the "Leaving Nothing Behind" Saga.
    Buccheri D; Piraino D; Andolina G
    Am J Cardiol; 2016 Jul; 118(2):308-9. PubMed ID: 27206913
    [No Abstract]   [Full Text] [Related]  

  • 22. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients".
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Galvão Braga C; Raposeiras-Roubin S; Lopez-Otero D; Cid-Alvarez B; Souto-Castro P; Trillo-Nouche R; Gonzalez-Juanatey JR
    Int J Cardiol; 2016 Sep; 219():264-70. PubMed ID: 27343418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of coronary bifurcation lesions: current knowledge and future perspectives.
    Elwany M; Palma GD; Cortese B
    Future Cardiol; 2018 Mar; 14(2):165-179. PubMed ID: 29372810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complex coronary intervention with overlapping of bioresorbable scaffolds. Case report and new insights review in the use of bioresorbable vascular scaffolds guided by optical coherence tomography].
    Macías E; Amador E
    Arch Cardiol Mex; 2016; 86(2):170-4. PubMed ID: 26907194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The EuroIntervention coronary bifurcation treatment supplement.
    Stankovic G; Lassen JF; Hildick-Smith D; Lefèvre T; Louvard Y; Gwon HC; Grundeken MJ
    EuroIntervention; 2015; 11 Suppl V():V9-11. PubMed ID: 25983181
    [No Abstract]   [Full Text] [Related]  

  • 27. Self-correction property a novel feature of bioresorbable coronary scaffolds.
    Diletti R; Ligthart JM; Ramdhan R; Van Mieghem NM
    Int J Cardiol; 2016 Jul; 214():417-8. PubMed ID: 27088402
    [No Abstract]   [Full Text] [Related]  

  • 28. Early U.S. Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold: Optimal Deployment Technique Using High Resolution Coronary Artery Imaging.
    Rizik DG; Padaliya BB
    J Interv Cardiol; 2016 Oct; 29(5):546-548. PubMed ID: 27492571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds.
    Lee WC; Chung WJ; Fang HY; Wu CJ
    Int J Cardiol; 2016 Mar; 206():58-60. PubMed ID: 26774833
    [No Abstract]   [Full Text] [Related]  

  • 30. Complete healing of a bifurcation lesion treated with the implantation of 2 bioresorbable vascular scaffolds with the T and small protrusion technique.
    Łanocha M; Lesiak M
    Kardiol Pol; 2019 Apr; 77(4):488-489. PubMed ID: 31025651
    [No Abstract]   [Full Text] [Related]  

  • 31. Coronary artery bifurcation with chronic total occlusion: A "biodegradable" strategy for a challenging treatment with optical coherence tomography analysis.
    Inga G; Buccheri D; Piraino D; Carella M; Andolina G
    Int J Cardiol; 2016 Sep; 218():23-24. PubMed ID: 27232906
    [No Abstract]   [Full Text] [Related]  

  • 32. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons from the GHOST-EU registry.
    Latib A; Capodanno D; Lesiak M; Tamburino C; Colombo A
    EuroIntervention; 2015; 11 Suppl V():V170-4. PubMed ID: 25983159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional optical coherence tomography evaluation of a left main bifurcation lesion treated with ABSORB® bioresorbable vascular scaffold including fenestration and dilatation of the side branch.
    Grundeken MJ; Kraak RP; de Bruin DM; Wykrzykowska JJ
    Int J Cardiol; 2013 Oct; 168(3):e107-8. PubMed ID: 23972365
    [No Abstract]   [Full Text] [Related]  

  • 35. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
    Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
    Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
    [No Abstract]   [Full Text] [Related]  

  • 37. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 38. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
    Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
    Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proximal optimization technique and kissing balloon inflations with the bioresorbable vascular scaffold for coronary bifurcation percutaneous coronary intervention.
    McGeoch RJ; Tanaka K; Overgaard CB; Bezerra HG; Džavík V
    Can J Cardiol; 2014 Nov; 30(11):1461.e5-7. PubMed ID: 25442451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
    Abizaid A; Ribamar Costa J
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):54-59. PubMed ID: 27797459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.